CN109200195A - 一种治疗糖尿病的中药组合物及其应用和装置 - Google Patents
一种治疗糖尿病的中药组合物及其应用和装置 Download PDFInfo
- Publication number
- CN109200195A CN109200195A CN201811324299.0A CN201811324299A CN109200195A CN 109200195 A CN109200195 A CN 109200195A CN 201811324299 A CN201811324299 A CN 201811324299A CN 109200195 A CN109200195 A CN 109200195A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- diabetes
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 23
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 23
- 240000004638 Dendrobium nobile Species 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 23
- 244000197580 Poria cocos Species 0.000 claims abstract description 23
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 23
- 240000000249 Morus alba Species 0.000 claims abstract description 22
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 22
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 21
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 21
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 21
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 238000001467 acupuncture Methods 0.000 claims abstract description 11
- 230000004936 stimulating effect Effects 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 11
- 239000002674 ointment Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 210000002429 large intestine Anatomy 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 210000000496 pancreas Anatomy 0.000 claims description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims 1
- 235000017491 Bambusa tulda Nutrition 0.000 claims 1
- 244000082204 Phyllostachys viridis Species 0.000 claims 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims 1
- 239000011425 bamboo Substances 0.000 claims 1
- 239000010977 jade Substances 0.000 claims 1
- 238000004080 punching Methods 0.000 claims 1
- 238000010257 thawing Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 239000008103 glucose Substances 0.000 abstract description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 10
- 230000003914 insulin secretion Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 102000004877 Insulin Human genes 0.000 abstract description 5
- 108090001061 Insulin Proteins 0.000 abstract description 5
- 229940125396 insulin Drugs 0.000 abstract description 5
- 239000011505 plaster Substances 0.000 abstract description 5
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 4
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000000638 stimulation Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 208000033065 inborn errors of immunity Diseases 0.000 abstract description 3
- 230000003204 osmotic effect Effects 0.000 abstract description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 abstract description 3
- 238000007920 subcutaneous administration Methods 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 12
- 230000006872 improvement Effects 0.000 description 8
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 6
- 235000013871 bee wax Nutrition 0.000 description 6
- 239000012166 beeswax Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000008159 sesame oil Substances 0.000 description 6
- 235000011803 sesame oil Nutrition 0.000 description 6
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 239000011787 zinc oxide Substances 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/002—Using electric currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rehabilitation Therapy (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Radiology & Medical Imaging (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗糖尿病的中药组合物及其应用和装置,涉及医疗卫生领域,所述中药组合物包括藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶,本发明将中药组合物用于治疗糖尿病的药贴,与微电流刺激仪结合使用,通过糖尿病反射穴位对一定频率的电脉冲刺激和冷敷黑膏药贴药物皮下渗透作用的感受,调节人体胰岛素分泌和血糖分解,促进病灶区代谢与免疫的正常循环形成,从而达到解除糖尿病人口渴、三多、免疫力低下、胰岛素分泌减少等症状,恢复人体正常代谢功能、增强分泌胰岛素、降低血糖等功效,恢复健康。
Description
技术领域
本发明涉及医疗卫生领域,尤其涉及一种治疗糖尿病的药贴及装置。
背景技术
糖尿病是由于胰岛素分泌绝对或相对不足以及靶组织对胰岛素的敏感性降低而引起的糖蛋白、脂肪、水、和电解质一系列代谢紊乱的临床综合症,其病因较为复杂,可由遗传因素和环境因素相互作用引起,可分为I型、Ⅱ型糖尿病,中医诊断糖尿病为消渴症。目前,西医对于糖尿病的治疗多采用药物为主,控制饮食,适当运动,虽然效果尚可,但是并发症很难控制除根。由于患者需要长期服用药物,不但会产生抗药性,还会产生诸如胃肠功能损伤、骨质疏松、内分泌紊乱、神经系统障碍及皮质素功能亢进等不良反应,而由于中医疗法具有副作用小,抗复发率效果好,能稳定病情,不扩散的特点,使得其在糖尿病领域得到了快速的应用和推广,但是,由于现有技术中的中医配方不合理,原料成分不恰当,导致糖尿病的改善效果不显著,改善效果一般。
发明内容
为解决上述技术问题,本发明提供一种治疗糖尿病的药贴及装置,本发明利用微电流刺激仪在传统针灸的基础上,通过糖尿病反射穴位对一定频率的电脉冲刺激和冷敷黑膏药贴药物皮下渗透作用的感受,调节人体胰岛素分泌和血糖分解,促进病灶区代谢与免疫的正常循环形成,从而达到解除糖尿病人口渴、三多、免疫力低下、胰岛素分泌减少、等症状,恢复人体正常代谢功能、增强分泌胰岛素、降低血糖等功效,恢复健康。
为实现本发明的技术目的,本发明一方面提供一种治疗糖尿病的中药组合物,包括:藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶。
采用本发明提供的上述配方的中药组合物能够平衡人体脏腑功能、气血阴阳平衡,糖尿病的中医辩证就是肺胃燥热、脾失健运、肝火旺、肾阴虚导致的功能性变化,需要肝肾同治、精血气互补,而本申请的上述配方中的生地、石斛、花粉、玄参、黄精、玉竹为滋阴、生津解渴为主;佐以藏红花、川芎为活血、补血加速血流量和血液代谢功能,辅以黄芪、太子参、茯苓、枣皮、三药、白术为使来调价人体肾气、脾胃、免疫力,从而调节人体胰岛素分泌和血糖分解,促进病灶区修复和代谢与免疫的正常循环形成,达到解除糖尿病人口渴、三多、免疫力低下、胰岛素分泌减少、等症状,恢复人体正常代谢功能、增强分泌胰岛素、降低血糖等功效,恢复健康。
其中,所述藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶的重量份配比为:
优选的,所述藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶的重量份配比为:
进一步优选的,所述藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶的重量份配比为:
为实现本发明的技术目的,本发明另一方面提供一种治疗糖尿病的药贴,按重量份计,包括:
优选的,按重量份包括:
进一步优选的,优选的,按重量份包括:
为实现本发明的技术目的,本发明再一方面提供一种治疗糖尿病药贴的方法,包括:
将藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶研磨成粉末,得到粉末状的中药细粉;
将制膏基本料融化搅拌均匀后,依次向其中加入所述粉末状的中药细粉边加边搅拌,保持文火,熬制成膏状,冷却后得到治疗糖尿病的药膏。
其中,所述藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶的重量份配比为:藏红花10-20份;川芎10-20份;黄芪20-40份;生地10-30份;太子参20-40份;茯苓10-30份;石斛20-40份;花粉8-28份;玄参10-30份;麦冬20-40份;枣皮5-25份;山药15-35份;黄精10-30份;玉竹20-40份;白术5-25份;桑叶20-40份。
优选的,所述藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶的重量份配比为:藏红花12-18份;川芎12-18份;黄芪24-36份;生地14-26份;太子参24-36份;茯苓14-26份;石斛24-36份;花粉12-24份;玄参14-26份;麦冬24-36份;枣皮9-18份;山药20-30份;黄精14-26份;玉竹25-35份;白术10-20份;桑叶25-35份。
进一步优选的,所述藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶的重量份配比为:藏红花15份;川芎15份;黄芪30份;生地20份;太子参30份;茯苓20份;石斛30份;花粉18份;玄参20份;麦冬30份;枣皮15份;山药25份;黄精20份;玉竹30份;白术15份;桑叶30份。
特别是,所述中药细粉的粒径为20-28μm。
其中,所述制膏基本料包括香油、松香、蜂蜡和氧化锌。
其中,所述香油、松香、蜂蜡和氧化锌的重量份配比为:香油2份、松香3份、蜂蜡2份、氧化锌1份。
特别是,所述制膏基本料与中药细粉的用量根据实际生产时膏药的规格及黏度设定。
为实现本发明的技术目的,本发明在一方面提供一种治疗糖尿病的装置,包括:
穴位微电流刺激仪以及摊铺在穴位微电流刺激仪电极片上的上述治疗糖尿病的中药组合物或药膏。
使用时,将摊铺有治疗糖尿病的中药组合物或药膏的电极片粘贴在糖尿病反射穴位上;开通微电流针灸穴位治疗仪,治疗15分钟,关闭电源;趴下电极针;保留带黑膏药的电极片在穴位敷贴6-9小时;每晚一次,15天一个疗程;连续三个疗程可明显降低血透临床相对数据或痊愈。
其中,糖尿病反射穴位包括脾俞、胰俞、胃俞、肾俞、气海、关元、涌泉、阴陵泉、承浆、意舍、关冲、然谷、水沟、承浆、金津、玉液、曲池、劳宫、太冲、行间、商丘、然谷、隐白、承浆、太溪、支正、阳池、照海、肾俞、小肠俞、手足小指尖。
有益效果
本发明利用微电流刺激仪在传统针灸的基础上,通过糖尿病反射穴位对一定频率的电脉冲刺激和冷敷黑膏药贴药物皮下渗透作用的感受,调节人体胰岛素分泌和血糖分解,促进病灶区代谢与免疫的正常循环形成,从而达到解除糖尿病人口渴、三多、免疫力低下、胰岛素分泌减少等症状,恢复人体正常代谢功能、增强分泌胰岛素、降低血糖等功效,恢复健康。
具体实施方式
下面结合具体实施例来进一步描述本发明,本发明的优点和特点将会随着描述而更为清楚。但这些实施例仅是范例性的,并不对本发明的范围构成任何限制。本领域技术人员应该理解的是,在不偏离本发明的精神和范围下可以对本发明技术方案的细节和形式进行修改或替换,但这些修改和替换均落入本发明的保护范围内。下述实施例中所使用的实验方法如无特殊说明,均为常规方法。下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。
需要说明的是,本发明所称的“份”的单位为重量计量单位,既可以是g,也可以是kg,也可以是mg等。
实施例1中药组合物制成的药膏
1、配比备料
称量藏红花15份;川芎15份;黄芪30份;生地20份;太子参30份;茯苓20份;石斛30份;花粉18份;玄参20份;麦冬30份;枣皮15份;山药25份;黄精20份;玉竹30份;白术15份;桑叶30份研磨成过500目筛的中药细粉,备用。
上述研磨可以是将上述称量的成分共同进行研磨,可以是分开进行研磨。
2、制膏
将香油和松香注入锅中,文火熔化,再放入蜂蜡、氧化锌熔化,搅拌均匀;最后依次加入中药细粉边加边搅拌,保持文火,熬制成膏状,冷却后取出即得治疗骨质增生的外用中药膏。
需要说明的是,香油、松香、蜂蜡、氧化锌为制药膏常用成分,其用量是基于药膏生产规格与黏度决定,本领域技术人员会根据实际生产需要进行调整。在本发明的一个实施例中,香油的用量为2份、松香的用量为3份、蜂蜡的用量为2份、氧化锌的用量为1份。
实施例2
除称量藏红花10份;川芎10份;黄芪20份;生地10份;太子参20份;茯苓10份;石斛20份;花粉8份;玄参10份;麦冬20份;枣皮5份;山药15份;黄精10份;玉竹20份;白术5份;桑叶20份外,其他均与实施例1相同。
实施例3
除称量藏红花20份;川芎20份;黄芪40份;生地30份;太子参40份;茯苓30份;石斛40份;花粉28份;玄参30份;麦冬40份;枣皮25份;山药35份;黄精30份;玉竹40份;白术25份;桑叶40份外,其他均与实施例1相同。
实施例4
除称量藏红花18份;川芎18份;黄芪36份;生地26份;太子参36份;茯苓26份;石斛36份;花粉24份;玄参26份;麦冬36份;枣皮18份;山药30份;黄精26份;玉竹35份;白术20份;桑叶25份外,其他均与实施例1相同。
实施例5
除称量藏红花12份;川芎12份;黄芪24份;生地14份;太子参24份;茯苓14份;石斛24份;花粉12份;玄参14份;麦冬24份;枣皮9份;山药20份;黄精14份;玉竹25份;白术10份;桑叶35份外,其他均与实施例1相同。
需要说明的是,在本发明的实施例中,藏红花的用量在10-20份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;川芎的用量在10-20份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;黄芪的用量在20-40份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;生地的用量在10-30份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;太子参的用量在20-40份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;茯苓的用量在10-30份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;石斛的用量在20-40份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;花粉的用量在8-28份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;玄参的用量在10-30份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;麦冬的用量在20-40份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;枣皮的用量在5-25份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;山药的用量在15-35份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;黄精的用量在10-30份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;玉竹的用量在20-40份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;白术的用量在5-25份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的;桑叶的用量在20-40份范围内的任一数值与其他成分进行使用都可以实现本发明的技术目的。
需要说明的是,本发明所称的“份”是指重量单位,例如g、kg、mg等。
试验例1
本申请在2017年和2018年于绵阳市第三人民医院老年综合科进行了两次的糖尿病治疗的临床验证,具体如下:
1、入选病例标准
年龄30-70岁,男女各半,总计60-90人,随机分成两组;按WHO(1999年)标准诊断2型糖尿病患者;入选时空腹血糖≤10毫摩尔/升,糖化血红蛋白≤10%。
2、治疗组给予中药穴位敷贴与微电流穴位刺激仪治疗,对照组给予二甲双胍片治疗。
3、治疗时间:30天为一疗程;共两个疗程治疗,两组均采用饮食及持续运动生活方式干预基础治疗。
4、排除标准
有急性感染、糖尿病急性并发症者;合并有严重心脑血管疾病及严重肝肾功能衰竭者(指ALT及AST高于正常高限2.5倍以上或血肌酐高于正常高限患者);治疗眼部病变患者及接受器官移植患者;植入有心脏起搏器;等其他电子设备患者;确认妊妇者。
5、结果统计
观察患者治疗前后的口渴喜饮、体倦乏力、多食易饥、少气懒言、精神面貌,同时检测治疗前后空腹血糖、餐后2h血糖值以及血氧饱和度,对上述指标均有改善的归为显效例,上述观察指标中有至少两项有改善,且检测指标至少有一项改善的归为有效例,上述观察指标中只有两项以下有改善,检测指标均无变化的归为无效例,统计结果如表1所示:
表1治疗效果统计表
根据表1的结果,以及患者表现可知,治疗组对气阴两虚的中医证候的改善与对照组比较有明显的效果,治疗组优于对照组,具体表现为①治疗组与对照组治疗后患者的空腹血糖、餐后2h血糖均有明显下降;②治疗组与对照组治疗后患者的血氧饱和度均有显著性差异,且两组间的改善比较差异性较为显著。可见,中药穴位敷贴与微电流穴位刺激仪治疗保证了降糖效果的同时,对糖尿病患者改善口渴喜饮、体倦乏力、多食易饥、少气懒言、精神面貌等气阴两虚的特征性症状方面有一定的优势,疗效可靠,值得临床推广应用。
Claims (6)
1.一种治疗糖尿病的中药组合物,其特征在于,包括藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶。
2.如权利要求1所述的中药组合物,其特征在于,按重量份计,所述藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶具有以下配比:
3.一种治疗糖尿病的药贴,其特征在于,包括以下重量份配比的成分:藏红花10-20份;川芎10-20份;黄芪20-40份;生地10-30份;太子参20-40份;茯苓10-30份;石斛20-40份;花粉8-28份;玄参10-30份;麦冬20-40份;枣皮5-25份;山药15-35份;黄精10-30份;玉竹20-40份;白术5-25份;桑叶20-40份。
4.一种治疗糖尿病药贴的方法,其特征在于,包括:
将藏红花、川芎、黄芪、生地、太子参、茯苓、石斛、花粉、玄参、麦冬、枣皮、山药、黄精、玉竹、白术、桑叶研磨成粉末,得到粉末状的中药细粉;
将制膏基本料融化搅拌均匀后,依次向其中加入所述粉末状的中药细粉边加边搅拌,保持文火,熬制成膏状,冷却后得到治疗糖尿病的药膏。
5.一种治疗糖尿病的装置,其特征在于,包括:
穴位微电流刺激仪以及摊铺在穴位微电流刺激仪电极片上的上述治疗糖尿病的中药组合物或药膏。
6.如权利要求5所述的装置,其特征在于,所述糖尿病反射穴位包括脾俞、胰俞、胃俞、肾俞、气海、关元、涌泉、阴陵泉、承浆、意舍、关冲、然谷、水沟、承浆、金津、玉液、曲池、劳宫、太冲、行间、商丘、然谷、隐白、承浆、太溪、支正、阳池、照海、肾俞、小肠俞、手足小指尖。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811324299.0A CN109200195A (zh) | 2018-11-08 | 2018-11-08 | 一种治疗糖尿病的中药组合物及其应用和装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811324299.0A CN109200195A (zh) | 2018-11-08 | 2018-11-08 | 一种治疗糖尿病的中药组合物及其应用和装置 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109200195A true CN109200195A (zh) | 2019-01-15 |
Family
ID=64995827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811324299.0A Pending CN109200195A (zh) | 2018-11-08 | 2018-11-08 | 一种治疗糖尿病的中药组合物及其应用和装置 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109200195A (zh) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1443544A (zh) * | 2002-03-07 | 2003-09-24 | 张世均 | 一种治疗糖尿病及防治并发症的中药降糖通脉灵及制备方法 |
| CN1833706A (zh) * | 2005-03-17 | 2006-09-20 | 黄菊 | 一种治疗糖尿病的药物及其制备方法 |
| CN101199756A (zh) * | 2007-12-17 | 2008-06-18 | 孙丹凤 | 一种治疗糖尿病的药物 |
| CN101279034A (zh) * | 2008-05-28 | 2008-10-08 | 贾宏雄 | 一种内服和外用结合治疗糖尿病的组合中药及制备方法 |
| CN103566177A (zh) * | 2012-07-26 | 2014-02-12 | 张夏思 | 治疗早期糖尿病的组合物及其制剂和制备方法 |
| CN104840738A (zh) * | 2015-05-18 | 2015-08-19 | 申洪恩 | 治疗糖尿病的药物及其生产方法 |
| CN107550715A (zh) * | 2017-10-18 | 2018-01-09 | 王铁森 | 电磁膏药贴和多功能理疗仪 |
-
2018
- 2018-11-08 CN CN201811324299.0A patent/CN109200195A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1443544A (zh) * | 2002-03-07 | 2003-09-24 | 张世均 | 一种治疗糖尿病及防治并发症的中药降糖通脉灵及制备方法 |
| CN1833706A (zh) * | 2005-03-17 | 2006-09-20 | 黄菊 | 一种治疗糖尿病的药物及其制备方法 |
| CN101199756A (zh) * | 2007-12-17 | 2008-06-18 | 孙丹凤 | 一种治疗糖尿病的药物 |
| CN101279034A (zh) * | 2008-05-28 | 2008-10-08 | 贾宏雄 | 一种内服和外用结合治疗糖尿病的组合中药及制备方法 |
| CN103566177A (zh) * | 2012-07-26 | 2014-02-12 | 张夏思 | 治疗早期糖尿病的组合物及其制剂和制备方法 |
| CN104840738A (zh) * | 2015-05-18 | 2015-08-19 | 申洪恩 | 治疗糖尿病的药物及其生产方法 |
| CN107550715A (zh) * | 2017-10-18 | 2018-01-09 | 王铁森 | 电磁膏药贴和多功能理疗仪 |
Non-Patent Citations (5)
| Title |
|---|
| 卜丽霞: "益气养阴治疗Ⅱ型糖尿病158例", 《内蒙古中医药》 * |
| 李俊英,杨临玲: "消渴灵方治疗糖尿病疗效观察", 《山西中医》 * |
| 林仙兴: "中药穴位贴敷控制糖尿病疗效观察", 《世界中医药》 * |
| 王素玲: "消渴Ⅱ号治疗气阴两虚兼血瘀型糖尿病(附40例临床观察分析)", 《中原医刊》 * |
| 骆珊: "益气滋阴降火法治疗糖尿病", 《湖北中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102743534B (zh) | 一种用于人体外敷发热的新型泥疗产品及其应用 | |
| CN101690789B (zh) | 一种治疗糖尿病的中药制剂 | |
| CN100353969C (zh) | 治疗再生障碍性贫血的药物 | |
| CN105232976A (zh) | 一种预防或/和治疗亚健康的组合物 | |
| CN105596735A (zh) | 一种治疗糖尿病的药物组合物 | |
| CN106418398A (zh) | 一种治疗糖尿病的食品 | |
| CN109200195A (zh) | 一种治疗糖尿病的中药组合物及其应用和装置 | |
| CN104587339A (zh) | 一种治疗化疗相关周围神经毒性的中药浸泡剂 | |
| CN102552755B (zh) | 一种治疗再生障碍性贫血的中药组合物 | |
| CN102008688A (zh) | 一种治疗周期性精神病的药物 | |
| CN102114185B (zh) | 一种治疗2型糖尿病胰岛素抵抗的药物 | |
| CN101862414A (zh) | 一种治疗阳萎的中药组合物 | |
| CN106138974A (zh) | 一种改善气虚体质的药物组合物和一种药砖及其制备方法 | |
| CN104623605A (zh) | 治疗乳腺癌的中药 | |
| CN103751355B (zh) | 一种具有提升白细胞效果的药物组合物 | |
| CN118340862B (zh) | 治疗化疗相关性呕吐的中药组合物及其制备方法、用途 | |
| CN104147244A (zh) | 参威口服液及其制备方法 | |
| CN101912454A (zh) | 一种治疗腰痛的药物及其制备方法 | |
| CN102366619A (zh) | 一种用于治疗气血虚、失眠引起月经不调的药物 | |
| CN103877204B (zh) | 一种治疗肥胖病的中药口服液及制备方法 | |
| CN103495079B (zh) | 一种治疗男性不育症的中药复方组合物及其制备方法及其应用 | |
| CN121197303A (zh) | 一种治疗元气不足证的中药组合物 | |
| CN101002852A (zh) | 一种补肾壮阳的中药复方制剂及其制备方法 | |
| CN107007748A (zh) | 改善体虚症状的中药组合物、药物及其制备方法和应用 | |
| CN106511946A (zh) | 一种治疗慢性肾小球性肾炎的中药及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190115 |
|
| RJ01 | Rejection of invention patent application after publication |